banner
Microtubule/Tubulin inhibitor, INH6, Purity ≥98%
Inquiry

Cat. No.: X24-08-YM232

Microtubule/Tubulin inhibitor, INH6, Purity ≥98%

Synonym: 1001753-24-7; INH 6; INH-6; N-[4-(2,4,6-Trimethylphenyl)-1,3-thiazol-2-yl]benzamide

  • MDL: MFCD04722622
  • CAS Number: 1001753-24-7
  • Compound CID: 7918451
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
INH6, soluble in warmed DMSO and warmed ethanol and insoluble in water, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
322.42
Molecular Formula
C19H18N2OS
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO (warmed): 58 mg/mL (179.88 mM); Water: insoluble; Ethanol (warmed): 10 mg/mL (31.01 mM)
Applications
INH6 is a cytoskeletal signaling inhibitor that can be used for its effective cell-killing activity in MDA-MB231, MDA-MB468, HeLa, and K562 cell lines.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0